Current diagnostic methods for ATTR-cardiac amyloidosis predominantly focus on assessing LV structure and function, often highlighting LV hypertrophy, granular sparkling of the myocardium, diastolic dysfunction, reduced longitudinal strain and regional sparing patterns as hallmark features [21]. This evidence concerns the gene TTR and cardiac hypertrophy.